Form 8-K - Current report:
SEC Accession No. 0001437749-25-014093
Filing Date
2025-05-01
Accepted
2025-05-01 16:09:24
Documents
15
Period of Report
2025-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K lmat20250501_8k.htm   iXBRL 8-K 29689
2 EXHIBIT 99.1 ex_810439.htm EX-99.1 265363
  Complete submission text file 0001437749-25-014093.txt   449729

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lmat-20250501.xsd EX-101.SCH 3578
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lmat-20250501_def.xml EX-101.DEF 11423
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lmat-20250501_lab.xml EX-101.LAB 15309
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lmat-20250501_pre.xml EX-101.PRE 11583
17 EXTRACTED XBRL INSTANCE DOCUMENT lmat20250501_8k_htm.xml XML 2835
Mailing Address 63 SECOND AVENUE BURLINGTON MA 01803
Business Address 63 SECOND AVENUE BURLINGTON MA 01803 781-221-2266
LEMAITRE VASCULAR INC (Filer) CIK: 0001158895 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33092 | Film No.: 25903146
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)